SIFI TO PRESENT NEW PRODUCTS AND SCIENTIFIC DATA DURING THE 42ND CONGRESS OF THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS
SIFI TO PRESENT NEW PRODUCTS AND SCIENTIFIC DATA DURING THE 42ND CONGRESS OF THE EUROPEAN SOCIETY OF CATARACT AND REFRACTIVE SURGEONS
CATANIA, Italy, Sept. 6, 2024 /PRNewswire/ -- SIFI, a leading international ophthalmic company, is pleased to announce that it will present two product innovations and new scientific data during the upcoming Congress of The European Society of Cataract and Refractive Surgeons (ESCRS) which will take place from September 6-10 in Barcelona (Spain).
意大利CATANIA，2024年9月6日/ PRNewswire /-SIFI，一家領先的國際眼科公司，很高興宣佈將在即將舉行的歐洲白內障和屈光手術學會（ESCRS）大會上發佈兩項產品創新和新的科學數據，該大會將於9月6日至10日在巴塞羅那（西班牙）舉行。
"SIFI is pioneering the integration of wavefront technology with ocular surface management technologies to advance the standard of care in refractive cataract surgery. By tailoring intraocular lens optics and ocular surface treatments, our solutions allow patients to achieve superior quality of vision," said Maria Cristina Curatolo, SIFI's Executive Director of Innovation and Medical Science.
「SIFI正在開創性地將波前技術與眼表管理技術相結合，以推進屈光白內障手術的標準。通過調整人工晶體光學和眼表處理，我們的解決方案使患者可以獲得更優質的視覺質量，」 SIFI創新和醫學科學執行董事Maria Cristina Curatolo表示。
Two new products will be introduced:
將推出兩款新產品：
- A new version of its EVOLUX extended monofocal intraocular lens (IOL) with an improved injection technology, allowing a smoother delivery and the freedom to choose between a push or screw technique;
- A new IOL calculator based on the Hoffer QST and Næser-Savini formulas, allowing a more precise calculation of spherical and cylindrical powers, also thanks to the use of artificial intelligence.
- 一款改進了注射技術的新款EVOLUX擴展單焦距人工晶體（IOL），可以更順暢地進行注入，並可以在推或擰的技術之間進行選擇；
- 一款基於Hoffer QSt和Næser-Savini公式的新型人工晶體（IOL）計算器，可以更精確地計算球面和散光度數，也得益於人工智能的應用。
A total of five podium presentation and five e-Posters will feature clinical outcomes on SIFI's solutions for cataract refractive surgery and ocular surface disease, such as EVOLUX, the presbyopia-correcting WELL FUSION system and the artificial tear Eyestil SYNFO. The schedule of scientific presentations is as follows:
共有五個發言和五個e-海報將展示SIFI關於白內障屈光手術和眼表疾病解決方案的臨床結果，例如EVOLUX，矯正老花眼的WELL FUSION系統和人工淚液Eyestil SYNFO。科學演示的日程安排如下：
Presented Posters on Sunday September 8th (14:15-15:45 | Room: Hall 6 & 7 - Pod 1)
於9月8日星期日展示的海報 （14:15-15:45 | 地點：大廳6和7-展臺1）
- Visual Performance, Subjective Satisfaction And Quality Of Life Effect Of A New Extended Monofocal Intraocular Lens (Iol) (Pagnacco C.);
- Multicentric Clinical Investigation On The Use Of Preservative- Free Ophthalmic Solution Based On Sodium Hyaluronate, Osmoprotectants, And Xanthan Gum In The Treatment Of Eye Discomfort, Particularly In Dry Eye (Molero-Senosiain M.);
- Visual and Refractive Outcomes after Implantation Of An Extended Monofocal Non-Diffractive Hydrophobic Intraocular Lens (Romualdi G.);
- Intermediate visual acuity comparison of two non-diffractive enhanced monofocal intraocular lenses (Rotter A.).
- 一個新的擴展單焦眼內鏡（IOL）的視覺表現，主觀滿意度和生活質量效果 （Pagnacco C.）
- 多中心臨床研究關於無防腐劑鈉透明質酸、滲透保護劑和黃原膠的眼藥水在眼部不適治療中的應用，尤其是乾眼（Molero-Senosiain M.）
- 擴展單焦非衍射性疏水性眼內鏡（Romualdi G.）的視覺和屈光結果
- 兩種非衍射增強單焦眼內鏡中間視力的比較（Rotter A.）
Free Paper Session on Tuesday 10th (11:00-12:30 | Room: Free paper podium 1)
週二10日的免費講座（11:00-12:30 | 房間：免費論文台1）
- Visual Performance, Subjective Satisfaction And Quality Of Life Effect After Bilateral Implantation Of Extended Depth Of Focus Intraoular Lens (Edof IOL) Compared To Trifocal IOL: A Randomized Clinical Trial (Pagnacco C.).
- 雙側擴景深眼內鏡（Edof IOL）與三焦點眼內鏡比較的視覺表現，主觀滿意度和生活質量效果：一項隨機對照臨床試驗（Pagnacco C.）
On Monday September 9th (13.00-14.00 - Room 8.10) SIFI will hold a Satellite Symposium "Ultimate Vision: Mastering Sight with Wavefront Engineering and Innovative Ocular Surface Management" featuring clinical updates from Dr. G. Savini, Prof. O. Findl, Dr. K. Gabric, Prof. E. Pedrotti and Prof. R. Mencucci.
9月9日星期一（13:00-14:00-8.10會議室）SIFI將舉辦衛星研討會「終極視力：通過波前工程和創新眼表管理掌握視力」，專家更新來自G. Savini博士, O. Findl教授, k. Gabric博士, E. Pedrotti教授和R. Mencucci教授的臨床信息
The list of e-Posters includes:
e-Poster清單包括：
- Functional outcomes of a new enhanced monofocal IOL (Savini G. – poster ID PO323)
- Long Term Visual Outcomes of an Extended Monofocal Intraocular Lens (EVOLUX ) after Cataract Surgery (Caparas V. – poster ID PO347)
- Visual Performance Of A New Advanced Monofocal Iol - Sifi Evolux (Gabrić K. – poster ID PO330)
- Evaluation Of Binocular Vision And Subjective Photic Disturbances After The Implantation Of Intraocular Lenses Between The Sifi Well Fusion Edof System And Three Trifocal Iol (Physiol Finevision, Alcon Clareon Panoptix And Ast Asqelio Trifocal) (Castanera D. – poster ID PO574)
- Estimated Visual Acuity And Clinical Validation For Three IOLs Based On Wavefront Engineering Technology (Vacalebre M. – poster ID PO592)
- 一種新的增強型單焦點人工晶體（Savini G. - 海報ID PO323）的功能結果
- 晶體植入術後延長單焦點人工晶體（EVOLUX）的長期視覺結果（Caparas V. - 海報ID PO347）
- Sifi Evolux一種新的高級單焦點人工晶體的視覺表現（Gabrić k. - 海報ID PO330）
- 在Sifi Well Fusion Edof系統和三款三焦點人工晶體（Physiol Finevision、Alcon Clareon Panoptix和Ast Asqelio Trifocal）之間植入人工晶體後的雙眼視覺和主觀光干擾評估（Castanera D. - 海報ID PO574）
- 基於波前工程技術的三種IOL的預估視力和臨床驗證（Vacalebre m. - 海報ID PO592）
ABOUT SIFI: SIFI is a leading international ophthalmic company, headquartered in Italy, featuring an integrated business model, from research & development to manufacturing and commercialization both in pharmaceutical and biomedical sectors. Since our foundation in 1935, our mission is to improve people's lives through meaningful innovation in eye care. SIFI exports to more than 40 countries worldwide with a direct presence in major European markets, Mexico and, through joint ventures, in China and the United Arab Emirates. More information available at
關於SIFI：SIFI是一家總部位於意大利的國際眼科公司，擁有整合的業務模式，從研發到製造和在藥品和生物醫藥領域的商業化。自1935年成立以來，我們的使命是通過眼部護理領域的有意義創新來改善人們的生活。SIFI在全球40多個國家進行出口並在主要歐洲市場、墨西哥以及通過合資企業在中國和阿聯酋擁有直接業務。更多信息請訪問
譯文內容由第三人軟體翻譯。